U.S. Gas Utilities Stock News

Agios Pharmaceuticals recently reported topline Phase 2 results for tebapivat in sickle cell disease and, citing insufficient differentiation versus other pyruvate kinase activators, decided to halt further development in this indication despite observing hemoglobin and hemolysis improvements and a safety profile aligned with prior trials. At the same time, the company is pursuing an alternative path in sickle cell disease through the FDA’s Priority Review of a supplemental New Drug...

In recent months, Lucid Group has come under growing scrutiny as mounting losses, very large negative gross margins, shrinking cash reserves, and leadership changes have fueled speculation about its financial stability and even potential bankruptcy risk. This pressure contrasts sharply with earlier optimism around its autonomous-vehicle partnerships and technology roadmap, highlighting how quickly confidence can shift when balance sheet strength and cash burn become central concerns. We’ll...

In July 2026, BigBear.ai expanded its generative AI platform for Department of War mission teams, adding air-gapped hardware, flexible tenant configurations, and both cloud-connected and fully local deployment options up to Top Secret/SCI classification. A key shift is the move to a refactored, model-agnostic platform with white-label, bring-your-own-model procurement choices, while phasing out the Ask Sage brand for Department of War users. Next, we’ll examine how the new air-gapped,...

Clean Harbors (CLH) is in focus after the company named long-time director Robert Willett as Chairman of the Board, following founder Alan S. McKim’s retirement from the board after more than four decades. See our latest analysis for Clean Harbors. Clean Harbors’ latest share price of $301.75 sits against a mixed recent pattern, with the share price declining over the past week but supported by a strong year to date share price return of 23.95% and a 5 year total shareholder return of...

Chinese manufacturers are rapidly expanding capacity in commodity NAND and DRAM, directly overlapping with NasdaqGS:SNDK core product areas. China is pushing ahead with domestic chip-making machinery, which may reduce reliance on foreign equipment suppliers. Regulatory and policy moves in China are creating roadblocks for international chip companies operating in the country. These developments introduce new competitive and supply chain risks for Sandisk that have not been fully discussed in...

Pagaya Technologies (PGY) recently closed an upsized, AAA-rated US$900 million personal loan ABS deal under its PAID 2026-5 program, a financing milestone supported by record year-to-date issuance volumes. See our latest analysis for Pagaya Technologies. The latest ABS milestone comes as Pagaya Technologies’ share price has climbed 25.91% over the past 90 days but remains down 23.88% year to date, with a 1 year total shareholder return that has declined 45.45%. This points to improving short...

Albemarle stock has rebounded strongly over the past year, yet the latest valuation checks and an overvalued read on market multiples leave investors weighing whether the recent price strength still leaves enough compensation for the risks. Albemarle has delivered a 57.5% return over the last year, which puts recent weakness into context and raises the question of how much of the recovery is already reflected in the share price. The long term cesium offtake agreement tied to the Case Lake...

In July 2026, Alnylam Pharmaceuticals reported past progress on its Alzheimer’s disease portfolio at the Alzheimer’s Association International Conference, including initiating the Phase 2 APPlauDS trial of mivelsiran in Down syndrome-associated Alzheimer’s disease, completing enrollment in the Phase 2 cAPPricorn-1 study in cerebral amyloid angiopathy, and advancing ALN-5288 into a first-in-human trial with Regeneron. Early mivelsiran data in Alzheimer’s disease showed sustained biomarker...

Why World Kinect’s latest earnings are moving the stock World Kinect (WKC) is back on investors’ radar after reporting a shift to net income in the second quarter, record adjusted earnings, higher gross profits and a lift to full year guidance. See our latest analysis for World Kinect. The earnings surprise and updated guidance appear to be feeding into strong momentum for World Kinect, with a 30 day share price return of 18.00% and a 90 day share price return of 48.30%. Over the longer term,...

ExxonMobil Holdings has delivered a very strong 223.0% return over the past 5 years, yet current checks suggest the stock may still trade below an intrinsic value estimate built from a Discounted Cash Flow (DCF) model and supported by earnings based multiples. That combination puts the focus on whether the recent strength in ExxonMobil’s share price has fully reflected the cash flows investors expect from its oil and gas business. A 223.0% 5 year return signals that ExxonMobil has already...

AI hardware stocks have just taken a hit, with NVIDIA, AMD and Dell all under pressure as investors question how much of the current AI buildout is backed by supplier financing rather than organic demand. That kind of broad risk-off move can create pricing dislocations, especially for large, diversified tech platforms that are only partially exposed to the AI cycle. This article walks through 3 stocks from our Large-Cap Diversified Tech Platforms screener that are closely tied to the latest...

Lakeland Financial (LKFN) has put up another solid quarter, with Q2 2026 revenue of US$69.2 million and basic EPS of US$1.13, backed by trailing 12 month net income of US$111.2 million and EPS of US$4.37 that reflect the 17.6% earnings growth cited over the past year. The company has seen revenue move from US$239.4 million to US$273.7 million on a trailing 12 month basis, while net income has shifted from US$94.6 million to US$111.2 million over the same period. This gives investors a clear...

RLI Corp. recently reported past second-quarter 2026 results, with revenue of US$575.57 million and net income of US$168.03 million, alongside completing a US$12.00 million share repurchase and appointing veteran reinsurance executive James H. Bradshaw to its board. The combination of higher earnings per share, a completed buyback, and added industry expertise on the board strengthens RLI’s capital management and governance profile. We’ll now examine how RLI’s higher quarterly earnings and...

Dover Corporation recently reported its second-quarter 2026 results, with sales of US$2,190.02 million and net income of US$312.25 million, alongside continued share repurchases under its 2023 buyback program. At the same time, CPC Biotech within Dover’s PSG segment launched the RevolveSD Series for large-scale bioprocessing, underscoring the company’s push into higher-value single-use biopharma solutions. Against this backdrop of higher quarterly earnings and ongoing share repurchases,...

Why NIO Stock Is Back in Focus After ES8 Milestone and CXMT Windfall NIO (NYSE:NIO) is drawing fresh attention after delivering its 130,000th third-generation ES8 SUV and seeing a very large gain on its US$23 million stake in memory maker CXMT. These two developments pull investor focus to both sides of NIO's story: operational progress in its core premium SUV line and the financial impact of exposure to an auto chip supplier, while higher memory costs highlight ongoing pressure on vehicle...

Hope Bancorp (HOPE) opened Q2 2026 with total revenue of US$138.5 million and basic EPS of US$0.26, supported by trailing 12 month EPS of about US$1.00 on revenue of US$534.0 million and net income of US$127.8 million. Over recent quarters the company has seen revenue move from US$77.1 million in Q2 2025 to US$139.4 million in Q4 2025 and US$129.9 million in Q1 2026. EPS shifted from a loss of US$0.22 in Q2 2025 to US$0.29 in Q4 2025 and US$0.23 in Q1 2026, setting up this latest print as...

ConnectOne Bancorp (CNOB) drew investor focus after reporting second quarter 2026 results that shifted from a net loss to net income and showed higher net interest income versus the prior year period. See our latest analysis for ConnectOne Bancorp. At a share price of $32.82, ConnectOne Bancorp has seen a 25.65% year to date share price return and a 37.66% total shareholder return over the past year, with recent quarterly earnings, dividend declarations and updated loan charge offs all...

Arm Holdings (NasdaqGS:ARM) is back in the spotlight after its architecture overtook x86 as the dominant platform in AI servers, supported by record fourth quarter revenue and the launch of an AGI data center CPU. See our latest analysis for Arm Holdings. Arm Holdings’ recent AI server milestones and AGI CPU launch come after a sharp share price run, with a 90 day share price return of 34.07% and a year to date share price return of 132.14%. At the same time, the 30 day share price return has...

In recent months, Teva Pharmaceutical Industries has accelerated its shift from generics to branded medicines, while absorbing near-term earnings dilution from its Emalex Biosciences acquisition and advancing duvakitug through clinical trials for ulcerative colitis and Crohn’s disease. This pivot toward higher-margin innovative drugs, with duvakitug viewed as a potential multi-billion-dollar opportunity if trials succeed, is becoming a central focus for how investors assess Teva’s...

Bank of Marin Bancorp (BMRC) opened Q2 2026 with total revenue of about US$34.3 million and basic EPS of US$0.58, providing a clear snapshot of the bank’s current income statement. The company’s revenue moved from US$30.9 million in Q3 2025 to US$33.7 million in Q1 2026 and then to US$34.3 million in Q2 2026. Over the same period, basic EPS shifted from US$0.47 to US$0.53 and then to US$0.58, giving investors a concrete view of recent earnings power as they consider the tension between...

Coca-Cola FEMSA (NYSE:KOF) has reported Q2 2026 revenue of about MX$76.3b and basic EPS of MX$4.73, with trailing twelve month EPS at MX$18.24 on revenue of roughly MX$296.2b, setting the tone for this earnings season update. The company has seen quarterly revenue move from about MX$72.3b and EPS of MX$25.27 in Q2 2025 to MX$76.3b and MX$4.73 in Q2 2026. Trailing twelve month revenue has shifted from roughly MX$288.0b with EPS of MX$48.56 to MX$296.2b and MX$18.24, giving investors a clearer...

Alliance Resource Partners (ARLP) has put fresh numbers on the table for Q2 2026, reporting revenue of US$551.6 million and basic EPS of US$0.62, supported by trailing twelve month EPS of US$2.05 and a trailing net margin of 12.1% compared with 10.2% a year earlier. The company has seen quarterly revenue move around the US$516 million to US$571 million range over the last six reported periods, while basic EPS has ranged from US$0.07 to US$0.73. This sets the backdrop for the current print and...

Recent permanent closures of Wendy's (WEN) locations in Ohio, alongside weaker U.S. sales and a 5.5% decline in global systemwide sales for early 2026, have sharpened investor focus on the stock. See our latest analysis for Wendy's. Those local closures and softer U.S. sales have coincided with a share price of $7.31, a 90 day share price return of 7.34% but a 1 year total shareholder return that has declined 24.57%. This suggests recent momentum has not reversed the longer term pressure. If...

Costamare (NYSE:CMRE) has reported Q2 2026 revenue of US$209.2 million and basic EPS of US$0.64, alongside trailing 12 month EPS of US$2.64 on revenue of US$857.4 million. This gives investors a clear view of the latest run rate. Over the past few quarters, revenue has moved from US$217.9 million and EPS of US$0.83 in Q2 2025 to US$209.2 million and EPS of US$0.64 in Q2 2026 as margins have shifted and filtered through to the trailing figures. With net margin on the trailing 12 month basis...